Fig. 2
From: Historical and projected public spending on drugs for rare diseases in Canada between 2010 and 2025
Annual spending on historical and pipeline drugs for rare diseases between 2010 and 2025. Public spending on Health Canada-approved historical drugs for rare diseases (DRDs) was evaluated from 2010 (11 DRDs) to 2020 (42 DRDs). Linear extrapolation was used to project spending on historical DRDs during 2021–2025, and projected spending on pipeline DRDs was added to produce the total annual spending on historical and pipeline DRDs during 2021–2025. All amounts are shown in millions of Canadian dollars. Assumptions that guided our projections for pipeline DRDs are listed in Tables 1 and 2